About Zyphar's Pharmaceutics Private Limited
Data last updated:
Zyphar's Pharmaceutics Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 17 February 2006 and has been in existence for over 20 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24231PN2006PTC022042. Its GSTIN is 27AAACZ2722P1ZX (Maharashtra).
The company has an authorised share capital of ₹4.95 Cr and a paid-up capital of ₹4.95 Cr. It is led by directors including Rajeshkumar Champalal Jain (Managing Director) and Mahendra Champalal Jain.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Office No. 102 & 103 Park Plaza First Floor Opp Kamala Nehru Park Erandwane, Pune, Maharashtra, India – 411004.
As per the financials filed for FY 2025, the company reported a revenue of ₹221.78 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹6.57 Cr (net margin 3%) and EBITDA of ₹14.7 Cr (EBITDA margin 6.6%). Revenue has grown at a compounded annual rate (CAGR) of 48% over three years and 43% over five years.
The company has about 146 employees on its provident fund (EPFO) records. Its group structure includes 2 subsidiaries.
As per MCA filings, the company has open charges of ₹20.75 Cr and satisfied charges of ₹6.89 Cr on record. Court records list 3 cases involving the company, including 3 filed against it. The company has 1 deal on record (1 rights issue); the latest was in March 2018.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website zyphars.com.
Company details
Contact details
Zyphar's Pharmaceutics Private Limited's registered office is in Pune, Maharashtra. Its website is zyphars.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressOffice No. 102 & 103 Park Plaza First Floor Opp Kamala Nehru Park Erandwane, Pune, Maharashtra, India – 411004
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Zyphar's Pharmaceutics Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Zyphar's Pharmaceutics is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Zyphar's Pharmaceutics Private Limited, buy the company report.
Financials of Zyphar's Pharmaceutics Private Limited
FY 2024 filings availableZyphar's Pharmaceutics Private Limited reported revenue of ₹221.78 Cr (up 283% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 43% over five years, including 283% growth in the latest year. EBITDA rose 129% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹14.7 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹6.57 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.6% | ||||
| Net Profit Margin | 3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Zyphar's Pharmaceutics Private Limited, buy the company report.
Board of directors of Zyphar's Pharmaceutics Private Limited
Zyphar's Pharmaceutics has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mahendra Champalal Jain | Director | 17 Feb 2006 | 20 Years 8 Months | Current |
| Rajeshkumar Champalal Jain Also directs: Anutej Vastunirman LLP, Sinsan Lifesciences Private Limited, Xion Pharmaceuticals Private Limited and 5 more | Managing Director | 17 Feb 2006 | 20 Years 8 Months | Current |
| Roshan Champalal Jain Also directs: Sinsan Lifesciences Private Limited, Xion Pharmaceuticals Private Limited, Sinsan Pharmaceuticals Private Limited and 4 more | Director | 17 Feb 2006 | 20 Years 8 Months | Current |
| Kapil Ganeshmal Sonigara | Director | 17 Feb 2006 | 20 Years 8 Months | Current |
Auditor
Zyphar's Pharmaceutics Private Limited is audited by Agrawal Dhand Motwani & Co. for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Agrawal Dhand Motwani & Co. | FY 2024 | 002824C |
Shareholding
The shareholding of Zyphar's Pharmaceutics Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Zyphar's Pharmaceutics Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 12 Sep 2025 | 101161431 | Others | ₹2 Cr | Open | |
| 22 Oct 2019 | 100300144 | Others | ₹1 Cr | Open | |
| 11 Jun 2019 | 100272442 | Others | ₹1 Cr | Open | |
| 06 Feb 2018 | 100158156 | Others | ₹50 Lakh | Open | |
| 10 Jun 2016 | 100036377 | Others | ₹25 Lakh | Open |
To see the full charge records of Zyphar's Pharmaceutics Private Limited, buy the company report.
Total charge records: 10 View all charges
Deals & funding
Zyphar's Pharmaceutics Private Limited has 1 deal on record (1 rights issue); the latest was in March 2018.
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2018 | Rights issue | ₹3.95 Cr | Investors: 4 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Zyphar's Pharmaceutics Private Limited has 3 court cases on record: 3 filed against it. All cases are disposed. Status as checked on 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 3 | 3 | 0 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Court case (LPETN) | Filed against the company by Bharat Serums and Vaccines Limited | Disposed |
| Bombay High Court | Interim or miscellaneous application | Filed against the company by Bharat Serums and Vaccines Limited | Disposed |
| Bombay High Court | Court case (COMIP) | Filed against the company by Bharat Serums and Vaccines Limited | Disposed |
To see the full case history of Zyphar's Pharmaceutics Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Zyphar's Pharmaceutics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Zyphar's Pharmaceutics has 2 subsidiary companies. This group structure data is as of FY 2024. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Sta-Co Nutra Products Private Limited | U15490PN2013PTC148501 | |
| Zyphar's Biopharmaceuticals Private Limited | U24299PN2021PTC206752 |
To see the full group structure of Zyphar's Pharmaceutics Private Limited, buy the company report.
Employees & EPFO
Zyphar's Pharmaceutics Private Limited has a workforce of 146 employees on its EPFO records as of Apr 08, 2025, across 1 active EPFO establishment.
GST
Zyphar's Pharmaceutics has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACZ2722P1ZX | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Zyphar's Pharmaceutics Private Limited, buy the company report.
Recent activity
Zyphar's Pharmaceutics Private Limited has 6 board changes on record since 2006: 4 appointments and 2 cessations. The latest: Sachin Ganeshmal Sonigara ceased to be Director on 09 Jan 2020.
12 earlier events are in the company report.
Frequently asked questions
Zyphar's Pharmaceutics is an active private limited company based in Pune, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 17 February 2006 (20+ years old) and is registered under CIN U24231PN2006PTC022042.
Zyphar's Pharmaceutics has 4 current directors:
- Rajeshkumar Champalal Jain - Managing Director
- Mahendra Champalal Jain - Director
- Roshan Champalal Jain - Director
- Kapil Ganeshmal Sonigara - Director
The latest financial statements of Zyphar's Pharmaceutics on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Zyphar's Pharmaceutics is 27AAACZ2722P1ZX, registered in Maharashtra.
The CIN (Corporate Identification Number) of Zyphar's Pharmaceutics is U24231PN2006PTC022042. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Zyphar's Pharmaceutics has 3 court cases on record: 3 filed against it.
Zyphar's Pharmaceutics was incorporated on 17 February 2006, making it 20+ years old. It is registered with the Registrar of Companies, Pune.
Zyphar's Pharmaceutics has 1 deal on record (1 rights issue); the latest was in March 2018.
Sachin Ganeshmal Sonigara ceased to be Director on 09 Jan 2020. Rajeshkumar Champalal Jain ceased to be Director on 01 Jan 2014. Kapil Ganeshmal Sonigara was appointed as Director on 17 Feb 2006. Zyphar's Pharmaceutics has 6 board changes on record in total.
Zyphar's Pharmaceutics can be reached through the website zyphars.com. Its registered office is in Pune, Maharashtra, India.